Status | Study |
Recruiting |
Study Name: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Condition: Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Pe Date: 2017-03-22 Interventions: Drug: Ixabepilone |
Recruiting |
Study Name: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Peritoneal Neoplasms Date: 2017-01-30 Interventions: Drug: Paclitaxel Paclitaxel 17 |
Not yet recruiting |
Study Name: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Condition: Advanced Cancer Ovarian Cancer Primary Peritoneal Carcinom Date: 2017-01-20 Interventions: Drug: Pembrolizumab Given intr |
Recruiting |
Study Name: A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer Condition: Cancer Ovaries Cancer Peritoneal Cancer, Fallopian Tube Date: 2017-01-13 Interventions: Drug: OMP-305B83 intravenous ( |
Recruiting |
Study Name: Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx Condition: Hydrosalpinx Infertility, Female Date: 2016-11-23 Interventions: Drug: Isoamyl 2-Cyanoacrylate |
Recruiting |
Study Name: Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Date: 2016-11-22 Interventions: Procedure: Baseline Biopsy Bas |
Recruiting |
Study Name: Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23 Condition: Ovarian Neoplasms Date: 2016-08-26 Interventions: Drug: Trabectedin Other Name: |
Recruiting |
Study Name: A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers Condition: Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Date: 2016-06-29 |
Recruiting |
Study Name: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers Condition: Gynecologic Neoplasms Epithelial Ovarian Cancer Uterine En Date: 2016-03-31 Interventions: Drug: Pembrolizumab Pembrolizumab 200mg IV Other Nam |
Recruiting |
Study Name: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer Condition: Epithelial Ovarian Cancer Peritoneal Cancer Fallopian Tube Date: 2016-01-21 Interventions: Other: Diagnostic analysis Molecular profiling |